StocksMarket.in

Trading Calls - Equity F&O

Buy Amara Raja Batteries; target of Rs 908: Cholamandalam Securities

Cholamandalam Securities’ research report on Amara Raja Batteries Amara Raja Batteries Ltd (ARBL), a Joint Venture between Amara Raja Group & Johnson Controls, each holding 26% stake, is

Read Full Article

Buy JK Cements; target of Rs 1260: Cholamandalam Securities

Cholamandalam Securities’ research report on JK Cements JK Cements is one of the largest cement players in North India. It manufactures grey cement, white cement and white cement

Read Full Article

Buy Alkem Laboratories; target of Rs 2150: Axis Direct

Axis Direct’s research report on Alkem Laboratories Alkem’s domestic formulations business (76% of sales) grew 15% YoY (grew 22% YoY adj for excise duty impact, realization gap under

Read Full Article

Buy Jagran Prakashan; target of Rs 190: Axis Direct

Axis Direct’s research report on Jagran Prakashan JAGP’s Q2 consol. print ad growth (up ~2% YoY) was impacted by 10% YoY decline across local (due to GST-led slowdown)

Read Full Article

Buy NTPC; target of Rs 197: Axis Direct

Axis Direct’s research report on NTPC Q2FY18 adjusted PAT grew 12% YoY at Rs 27 bn (vs. our estimate Rs 26 bn) in tandem with 17% YoY rise

Read Full Article

Buy Suprajit Engineering; target of Rs 315: Axis Direct

Axis Direct’s research report on Suprajit Engineering Q2FY18 consolidated EBITDA was in line with our estimate. Aftermarket revenue (~20% of sales) remained subdued in the wake of GST

Read Full Article

Buy Apollo Hospitals; target of Rs 1349: Axis Direct

Axis Direct’s research report on Apollo Hospitals Capex cycle (bed capacity up 50% from FY14) coming to an

Read Full Article

Buy JK Cement; target of Rs 1220: Axis Direct

Axis Direct’s research report on JK Cement JK Cement’s (JKCE) Q2FY18 EBITDA at Rs 2.1 bn (up 30%

Read Full Article

Buy Cadila Healthcare; target of Rs 500: Axis Direct

Axis Direct’s research report on Cadila Healthcare Cadila’s Q2 EBITDA (+67% YoY, 22% above our estimate) was driven

Read Full Article

Buy Navkar Corporation; target of Rs 205: Axis Direct

Axis Direct’s research report on Navkar Corporation Panvel volumes improved ~4% QoQ (up ~3% Yo) led by 12%

Read Full Article

Buy Dilip Buildcon; target of Rs 1227: Axis Direct

Axis Direct’s research report on Dilip Buildcon Dilip Buildcon’s (DBL) Q2FY18 sales grew 73% YoY at Rs 15.8

Read Full Article

Buy Phoenix Mills; target of Rs 605: Axis Direct

Axis Direct’s research report on Phoenix Mills Rental income collectively grew 9% YoY, despite slower consumption growth of

Read Full Article

Buy EID Parry; target of Rs 520: Axis Direct

Axis Direct’s research report on EID Parry EID reported Q2 PAT of ~800 mn, flat YoY. Cane availability

Read Full Article

Buy Sadbhav Engineering; target of Rs 416: Axis Direct

Axis Direct’s research report on Sadbhav Engineering Sadbhav’s (SEL) Q2FY18 standalone revenue (up 13% YoY) was below consensus/our

Read Full Article

Buy Gateway Distriparks; target of Rs 280: Axis Direct

Axis Direct’s research report on Gateway Distriparks Gateway Distriparks’ (GDPL) Q2 witnessed strong rebound in rail performance: (a)

Read Full Article

Hold AIA Engineering; target of Rs 1328: Centrum

Centrum’s research report on AIA Engineering AIA Engineering Ltd (AIAE), on a consolidated basis, for Q2FY18 reported weak

Read Full Article

Hold Canara bank; target of Rs 390: SPA Securities

SPA Securities’ research report on Canara bank Canara bank reported better NIMs at 2.60% (25bps y-o-y & 4bps

Read Full Article

Nifty likely to shed 37 points at opening bell: Maximus Securities

Maximus Securities’ Daily Report: F&O Outlook: Nifty PCR-OI has increased to 1.20 from 1.03. The rise in the

Read Full Article

Nifty may open on flat note: Maximus Securities

Maximus Securities’ derivative report: Nifty PCR-OI has increased to 1.03 from 0.97. The rise in the ratio may

Read Full Article

Archives